These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

758 related items for PubMed ID: 22156854

  • 1. Fidaxomicin: a novel macrocyclic antibiotic approved for treatment of Clostridium difficile infection.
    Venugopal AA, Johnson S.
    Clin Infect Dis; 2012 Feb 15; 54(4):568-74. PubMed ID: 22156854
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB, Czosnowski QA.
    Ann Pharmacother; 2012 Feb 15; 46(2):219-28. PubMed ID: 22318930
    [Abstract] [Full Text] [Related]

  • 4. Fidaxomicin: a minimally absorbed macrocyclic antibiotic for the treatment of Clostridium difficile infections.
    Soriano MM, Liao S, Danziger LH.
    Expert Rev Anti Infect Ther; 2013 Aug 15; 11(8):767-76. PubMed ID: 23977933
    [Abstract] [Full Text] [Related]

  • 5. Fidaxomicin: the newest addition to the armamentarium against Clostridium difficile infections.
    Lancaster JW, Matthews SJ.
    Clin Ther; 2012 Jan 15; 34(1):1-13. PubMed ID: 22284993
    [Abstract] [Full Text] [Related]

  • 6. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
    Cornely OA.
    Clin Microbiol Infect; 2012 Dec 15; 18 Suppl 6():28-35. PubMed ID: 23121552
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Fidaxomicin: first-in-class macrocyclic antibiotic.
    Mullane KM, Gorbach S.
    Expert Rev Anti Infect Ther; 2011 Jul 15; 9(7):767-77. PubMed ID: 21810048
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Advances in the treatment of Clostridium difficile with fidaxomicin: a narrow spectrum antibiotic.
    Sears P, Ichikawa Y, Ruiz N, Gorbach S.
    Ann N Y Acad Sci; 2013 Jul 15; 1291():33-41. PubMed ID: 23672600
    [Abstract] [Full Text] [Related]

  • 11. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR.
    Am J Geriatr Pharmacother; 2012 Feb 15; 10(1):14-24. PubMed ID: 22260856
    [Abstract] [Full Text] [Related]

  • 12. Fidaxomicin: a new option for the treatment of Clostridium difficile infection.
    Johnson AP, Wilcox MH.
    J Antimicrob Chemother; 2012 Dec 15; 67(12):2788-92. PubMed ID: 22865382
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis.
    Hostler CJ, Chen LF.
    Expert Opin Pharmacother; 2013 Aug 15; 14(11):1529-36. PubMed ID: 23683070
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.